Biological Immunology

Simponi

Payments companies reported to CMS as associated with Simponi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.4Massociated payments (2023-2025)

17,490clinicians with associated payments

5companies reporting

By year

2023 $627K

2024 $362K

2025 $432K

Payments reported as associated with Simponi, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Gastroenterology (Internal Medicine) $387K

Dermatology $238K

Physician Assistant $219K

Family $124K

Medical $70K

Nurse Practitioner $67K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Simponi

These are the largest totals companies reported as associated with Simponi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Kevin Winthrop	Portland, OR	Infectious Disease	$12,025.00
Francis Farraye	Jacksonville, FL	Gastroenterology (Internal Medicine)	$7,888.28
Parambir Dulai	Chicago, IL	Gastroenterology (Internal Medicine)	$7,851.36
Faten Aberra	Philadelphia, PA	Gastroenterology (Internal Medicine)	$7,689.10
Harry Thomas	Austin, TX	Gastroenterology (Internal Medicine)	$6,730.88
Jose Scher	New York, NY		$5,486.25
Shirish Amin	Indiana, PA	Gastroenterology (Internal Medicine)	$1,543.57
Lucy Nusrala	Portland, OR	Physician Assistant	$1,426.91
Jeffrey Hyams	Hartford, CT	Pediatric Gastroenterology	$1,240.00
Mark Davis	Lake Oswego, OR	Medical	$1,138.42

Prescribed Simponi?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.